Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound
US-11889750-B2 · Jan 30, 2024 · US
US12459966B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12459966-B2 |
| Application number | US-202217570868-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 7, 2022 |
| Priority date | Feb 2, 2021 |
| Publication date | Nov 4, 2025 |
| Grant date | Nov 4, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compound of Formula I,is provided. In Formula I, rings A, B, C, and D are 5- or 6-membered rings; each of X1-X5, X21-X22, and Z1-Z3 is C or N; each of L1, L2, and L3 is selected from a direct bond or a divalent linker; each of a and b is 0 or 1; Y is O, S, Se, or NRY; W is O, S, NRW, C═RW, or CRWRW′; up to 1 of Z1 to Z3 is N; each R, R′, RA, RB, RC, RD, RY, RW, and RW′ is hydrogen or a substituent. Formulations, OLEDs, and consumer products containing the same are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A compound of Formula I: wherein rings A, B, C, and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; each of X 1 , X 2 , X 3 , X 4 , X 5 , X 21 , X 22 , Z 1 , Z 2 , and Z 3 is independently C or N; each of L 1 , L 2 , and L 3 is independently selected from the group consisting of a direct bond, BR, NR, PR, O, S, Se, C═R, C═O, S═O, SO 2 , CRR′, SiRR′, GeRR′, aryl, heteroaryl, alkyl, and cycloalkyl; each of a and b is independently 0 or 1; at least one of a and b is 1; L 2 is not present if a=0; L 3 is not present if b=0; Y is selected from the group consisting of O, S, Se, and NR Y ; W is selected from the group consisting of O, S, NR W , C═R W , and CR W R W′ ; at most one of Z 1 , Z 2 , and Z 3 is N; each of R A , R B , R C , and R D independently represents mono to the maximum allowable substitution, or no substitution; each R, R′, R A , R B , R C , R D , R Y , R W , and R W′ is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, selenyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and any two of R, R′, R A , R B , R C , R D , R Y , R W , and R W′ can be joined or fused to form a ring. 2. The compound of claim 1 , wherein each R, R′, R A , R B , R C , R D , R Y , R W , and R W′ is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 3. The compound of claim 1 , wherein each of rings A, B, C, and D is independently selected from the group consisting of pyridine, benzene, pyrrole, and imidazole. 4. The compound of claim 1 , wherein L 1 is a direct bond. 5. The compound of claim 1 , wherein a is 1 and L 2 is a direct bond. 6. The compound of claim 1 , wherein b is 1 and L 3 is a direct bond. 7. The compound of claim 1 , wherein W is O. 8. The compound of claim 1 , wherein W is NR W or C═R W , wherein R W is joined or fused with R D to form a ring, or Y is NR Y and R W is joined or fused with R to form a ring, or both. 9. The compound of claim 1 , wherein Y is O. 10. The compound of claim 1 , wherein Y is NR Y , wherein R Y comprises aryl, which can be substituted. 11. The compound of claim 10 , wherein R is phenyl, which is ortho substituted by a substituent selected from the group consisting of aryl, alkyl, cycloalkyl, and combinations thereof. 12. The compound of claim 1 , wherein Z 2 or Z 3 is N. 13. The compound of claim 1 , wherein each of X 1 , X 2 , X 3 , X 4 , and X 5 is C. 14. The compound of claim 1 , wherein the compound has a structure selected from the group consisting of: wherein: X 6 to X 22 are each independently C or N R E has the same definition as R A -R D ; and each of Y E and Y W is independently selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO2, CRR′, SiRR′, and GeRR′. 15. The compound of claim 1 , wherein the compound has a structure selected from the group consisting of: wherein: each of l, m, n, and o is independently an integer from 1 to 331; each of p, q, and r is independently an integer from 1 to 337, R A1 l is Rl, R A2 m is Rm, R A3 n is Rn, R A4 o is Ro, for p=1 to 331, Y A1 p is N-Rp, for q=1 to 331, Y A2 q is N-Rq, for r=1 to 331, Y A1 r is N-Rr, each of Y A1 332, Y A2 332, and Y A3 332 is O, each of Y A1 333, Y A2 333, and Y A3 333 is S, each of Y A1 334, Y A2 334, and Y A3 334 is CMe 2 , each of Y A1 335, Y A2 335, and Y A3 335 is SiMe 2 , each of Y A1 336, Y A2 336, and Y A3 336 is CPh 2 , each of Y A1 337, Y A2 337, and Y A3 337 is SiPh 2 , and wherein R1 to R331 are defined as follows:
Interrelation of parameters between multiple constituent active layers or sublayers, e.g. HOMO values in adjacent layers · CPC title
Highest occupied molecular orbital [HOMO], lowest unoccupied molecular orbital [LUMO] or Fermi energy values · CPC title
Triplet emission · CPC title
comprising dopants · CPC title
characterised by the electroluminescent [EL] layers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.